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Abstract
Background: There is accumulating evidence that host heparan sulphate proteoglycans play an important role in
the life cycle of Plasmodium through their heparan sulphate chains, suggesting that genetic variations in genes
involved in heparan sulphate biosynthesis may influence parasitaemia. Interestingly, Hs3st3a1 and Hs3st3b1
encoding enzymes involved in the biosynthesis of heparan sulphate are located within a chromosomal region
linked to Plasmodium chabaudi parasitaemia in mice. This suggests that HS3ST3A1 and HS3ST3B1 may influence P.
falciparum parasitaemia in humans.
Methods: Polymorphisms within HS3ST3A1 and HS3ST3B1 were identified in 270 individuals belonging to 44
pedigrees and living in Burkina Faso. Linkage and association between parasitaemia and the polymorphisms were
assessed with MERLIN and FBAT. A genetic interaction analysis was also conducted based on the PGMDR
approach.
Results: Linkage between P. falciparum parasitaemia and the chromosomal region containing HS3ST3A1 and
HS3ST3B1 was detected on the basis of the 20 SNPs identified. In addition, rs28470223 located within the promoter
of HS3ST3A1 was associated with P. falciparum parasitaemia, whereas the PGMDR analysis revealed a genetic
interaction between HS3ST3A1 and HS3ST3B1. Seventy-three significant multi-locus models were identified after
correcting for multiple tests; 37 significant multi-locus models included rs28470223, whereas 38 multi-locus models
contained at least one mis-sense mutation within HS3ST3B1.
Conclusion: Genetic variants of HS3ST3A1 and HS3ST3B1 are associated with P. falciparum parasitaemia. This
suggests that those variants alter both the function of heparan sulphate proteoglycans and P. falciparum
parasitaemia.
Keywords: HS3ST3A1, HS3ST3B1, Heparan sulphate biosynthesis, Plasmodium falciparum, Malaria, Parasitaemia,
Family-based association, Genetic interaction
Background
Plasmodium falciparum malaria is transmitted to
humans through the bite of infected female Anopheles
mosquitoes. Sporozoites that have been injected into the
skin migrate from the site of injection, and reach the
liver, where they invade hepatocytes and change into
merozoites; merozoites penetrate and replicate inside
red blood cells. Heparan sulphate proteoglycans
(HSPGs) may play an important role in the biology of
Plasmodium through their carbohydrate chains (heparan
sulphate) in both the mammalian host and the vector.
Anopheles heparan sulphate has been shown to bind cir-
cumsporozoite protein (CSP), suggesting a role for the
carbohydrate chains within Anopheles salivary glands for
infection and transmission of the parasite [1]. CSP also
interacts with the HSPGs on host liver cells, and this
interaction has been shown to determine the choice
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between migrating through or invading the cell [2].
Highly sulphated HSPGs of hepatocytes activates the
rodent malaria parasite Plasmodium berghei for inva-
sion, whereas the parasite migrates through cells with
low sulphated HSPGs in skin and endothelium [2]. In
addition, a P. falciparum merozoite antigen (EBA-140)
has been shown to bind to red blood cells in a heparan
sulphate-manner, whereas soluble heparan sulphate and
heparin inhibit the merozoite invasion into red blood
cells [3,4]. Finally, heparan sulphate is thought to be a
receptor for PfEMP1 expressed on infected red blood
cells (iRBC), and to mediate the binding of iRBC on
endothelial cells or other red blood cells [4-6].
These observations suggest that the outcome of
malaria infection may be influenced by variations in the
biosynthesis of heparan sulphate, owing to genetic varia-
tions within genes encoding the enzymes involved.
These include O-sulphotransferases, which catalyze 2-O,
6-O, or 3-O sulphation [7]. The O-sulphation steps are
the last steps of the synthesis of heparan sulphate (HS);
the sulphation level is a measure of the completion of
this synthesis, and is thought to influence the binding
properties and therefore the function of HSPGs [7]. The
3-O-sulphation is thought to be a rare event, whereas
the 3-O sulphated HS has been shown to serve as an
entry receptor of Herpes Simplex Virus 1 (HSV-1) [8].
Interestingly, whereas only one 2-O sulphotransferase,
and one 6-O sulphotransferase are known, seven iso-
forms of 3-O sulphotransferases have been reported
[7,9]. The genes encoding the 3-O sulphotransferases
are located in different chromosomal regions except for
HS3ST3A1 and HS3ST3B1, and the only significant
sequence homology between these proteins occurs in
the sulphotransferase domains. Nevertheless, HS3ST3A1
and HS3ST3B1, which encode the 3-O sulphotrans-
ferases 3-OST-3A1 and 3-OST-3B1 respectively, are 700
kb apart in the same chromosomal region, and show a
high sequence identity [10]. 3-OST-3B1, which has a
sulphotransferase domain 99.2% identical to that of 3-
OST-3A1, sulphates an identical disaccharide [11].
Recently, HS3ST3A1 that encodes 3-OST-3A1 has been
associated with mother-to-child transmission of human
immunodeficiency virus (HIV) through a genome-wide
association study [12], whereas HSPGs promotes HIV
penetration through endothelial cells in a heparan sul-
phate-manner [13]. This supports the hypothesis that
genetic variations within the genes encoding 3-O-sul-
photransferases may affect the susceptibility to infec-
tious diseases, such as malaria.
There is a growing body of evidence for human
genetic factors controlling the outcome of infection.
Familial aggregation and segregation analyses showed
the existence of a genetic component of phenotypes
related to P. falciparum malaria resistance or
susceptibility [14,15]. Several candidate genes have
been associated with resistance against severe malaria
[16]. Linkage or association analyses mapped various
loci controlling mild malaria and/or parasitaemia in
humans [15,17-19]. The first chromosomal regions
that showed linkage to mild malaria and/or parasitae-
mia were 6p21.3 and 5q31-q33 [15,17,20,21]. However,
a limited number of confirmed alleles involved in
human malaria have been identified [22,23]. In crosses
between genetically defined strains of mice, chromoso-
mal regions responsible for the genetic variance of
complex traits can be mapped as quantitative trait loci
(QTL) in experimental populations available for pre-
cise study under defined conditions. Linkage analyses
based on experimental crosses have been done in
mice, leading to the mapping of loci controlling Plas-
modium chabaudi parasitaemia (Char1-10) or cerebral
malaria [22,24,25]. Notably, such analyses mapped two
loci on chromosomes 17 (Char3) and 11 (Char8),
which show extensive conservation of synteny with
human chromosomes 6p21.3 and 5q31-q33, respec-
tively [26,27]. The 95% confidence interval of Char8
(chromosome 11 between D11Mit231 and D11Mit30)
contained mostly genes, the orthologs of which are
located in human chromosome 5q31-q33. Neverthe-
less, it also contained genes, the orthologs of which
are located in human chromosome 17; these include
Hs3st3a1 and Hs3st3b1, which encode 3-O sulpho-
transferases in mice [26,27], suggesting that genetic
variations within HS3ST3A1 and HS3ST3B1 may influ-
ence parasitaemia in humans. This hypothesis was
further supported by a linkage study based on micro-
satellite markers in humans (P.Rihet, unpublished
data). This prompted us to screen HS3ST3A1 and
HS3ST3B1 in a population living in an endemic area
in Burkina Faso to identify polymorphisms, to evaluate
their linkage and association with parasitaemia, and
gene-gene interactive effects by using the pedigree-




The study subjects live in a rural area, Logoforousso, a
village to the south-west of Bobo-Dioulasso (Burkina
Faso). The population and the area of parasite exposure
have been extensively described [29]. Volunteer families
were randomly selected from 3,500 inhabitants.
Informed consent was then obtained individually from
all participants or their parents. The protocol was
approved by the national medical authorities of Burkina
Faso. Four mosquito capture sites were chosen, and
mosquitoes were collected outdoors 4 days each month
(during two nights every 2 weeks). The inoculation rate
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was 230 infective bites per person per year. The study
population comprised 270 subjects from 44 pedigrees
corresponding to 71 nuclear families. Eighty-seven par-
ents and 183 siblings were available for genotyping and
retained for linkage analysis. The mean age of the sib-
lings was 9.9 ± 4.4 (three to 25 years).
Phenotyping
Parasitaemia was measured as described [29]. During
two years, each family in the rural area was visited 28
times. Blood samples were taken from all individuals
present, and only asymptomatic P. falciparum parasitae-
mia measurements were considered in this study. The
mean number of asymptomatic P. falciparum parasitae-
mia measurements per subject was 14.9 + 8.1 (range
one to 28). The parasitaemia was defined as the number
of parasitized erythrocytes observed per microlitre in
thin blood films. The analysis was conducted on a loga-
rithmic transformation of parasitaemia adjusted for sea-
sonal transmission and for age that showed a significant
effect on parasitaemia (P < 10-4). The standardized resi-
dual was the phenotype used for linkage and association
analyses.
Genotyping
Each subject underwent a venipuncture, and DNA was
extracted from mononuclear cells separated by Ficoll-
Hypaque density gradient as described [15]. DNA con-
centration was assessed with a biophotometer (Eppen-
dorf, Le Pecq, France). The DNA samples (n = 270)
were subjected to prior whole-genome amplification
with the Illustra GenomiPhi V2 DNA Amplification Kit
from General Electric Healthcare (GE Healthcare Bios-
ciences, Pittsburgh, PA, USA) before genotyping. To
identify mutations in the promoter region, in all the
coding regions and the intron-exon border, defined PCR
products were sequenced. All primer pairs were
designed with the PRIMER 3 program [30]. There is a
strong homology between HS3ST3A1 coding sequence
and that of HS3ST3B1, particularly between exon 2
sequences [10]. Therefore, a first set of primers corre-
sponding to non-coding regions that display sequence
variation were designed. PCR was performed with a first
set of primers leading to a large product, whereas
sequencing reaction was performed with additional
internal primers (Additional file 1). Before starting the
sequencing reaction, the PCR products were purified
with the Qiagen QIAquick PCR purification kit (Qiagen,
Hilden, Germany) and quantified by 2% agarose gel elec-
trophoresis. Sequencing reaction was performed with
the CEQ DTCS kit (Beckman Coulter, Fullerton, CA,
USA) and a CEQ 8800 automated fluorescent sequencer
(Beckman Coulter).
Allele frequencies, haplotype reconstruction and linkage
disequilibrium analysis
The compatibility with Mendelian inheritance of marker
alleles was checked with the FBAT and MERLIN pro-
grams [31,32]. All genotypes passed a Mendelian check
with the program FBAT. Using MERLIN, improbable
recombination events from SNP maps were checked to
detect genotyping errors.
Allele frequencies were calculated by gene counting
and deviation from Hardy-Weinberg equilibrium was
tested using a Chi-2-test with 1 degree of freedom. Hap-
lotypes were generated based on family genotypic data
with MERLIN. Pair-wise LD (Linkage Disequilibrium)
was calculated with Haploview and graphical overview
of linkage disequilibrium (GOLD) [33,34]. LD between
pairs of biallelic markers was tested by the r2 statistic, r2
= (p11p22-p12p21)2/p1p2q1q2, where p11, p22, p12,
and p21 were two-locus haplotype frequencies, and p1,
p2, q1, and q2 were allele frequencies. r2 is the standard
c2 statistic divided by the number of chromosomes in
the sample. It ranges from 0 to 1. When r2 is 1, SNPs
are in complete LD.
Statistical analyses
Multipoint linkage analyses were performed for sibship
and half-sibship data using the software package the
MERLIN Package [31]. The regression-based procedure
was used for quantitative trait linkage analysis [35].
Combined association and linkage analyses of quantita-
tive traits were carried out using the FBAT program
and the QTDT program [32,36]. FBAT calculates a Z
score and a two-side P value based on a normal approx-
imation. Association in the presence of linkage was
assessed using the orthogonal model released in the
QTDT program [36]. P values were calculated using the
likelihood-ratio criterion.
Genetic interactions were analysed by using the pedi-
gree-based generalized multifactor dimensionality reduc-
tion method (PGMDR) [28]. The PGMDR is a score-
based MDR method that uses the same data reduction
strategy as does the original MDR method to detect
non-linear genetic interactions [37]. Briefly, the informa-
tive siblings were randomly divided into nearly 10 nearly
equal subsets, and the cross-validation was repeated 10
times. Each time, nine subsets were used as the training
set to construct a binary model with high risk and low
risk genotype combinations, while the last subset was
considered the testing set. The odds ratio, the corre-
sponding 95% confidence interval, and the P value were
calculated for the training set. The testing set was used
to estimate the prediction accuracy of the model, which
is the ratio of correct classifications to the total number
of instances classified. The non-parametric sign test was
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used to evaluate the significance of the prediction
accuracy.
The false discovery rate (FDR) procedure was per-
formed to account for the multiple tests performed [38];
an FDR of 5% and an FDR of 10% were applied. Multi-
ple test corrections were carried out for all the linkage,
association, and interaction analyses.
Results
Descriptive analyses
Twenty polymorphisms were identified in the promoter,
the exons, the intron-exon junctions, and the 3’ untrans-
lated region of HS3ST3A1 and HS3ST3B1 (Table 1).
Notably, some SNPs annotated both in HS3ST3A1 and
HS3ST3B1 were found in either HS3ST3A1 or
HS3ST3B1 (Figure 1). All SNPs passed a Mendelian
check, and the detectable genotype errors were < 0.1%
based on improbable recombination events from dense
SNP maps. There was no deviation from the Hardy-
Weinberg equilibrium. Figure 2 shows pair-wise linkage
disequilibrium coefficients. There was a significant link-
age disequilibrium between some SNPs within either
HS3ST3A1 or HS3ST3B1, whereas no linkage disequili-
brium was detected between HS3ST3A1 and HS3ST3B1.
In particular, there was a highly significant linkage dise-
quilibrium between rs3744337 and rs3744335 (r2 = 0.72;
P < 0.0001) within HS3ST3A1; there was also a highly
significant linkage disequilibrium between rs2072243
and rs2072242 (r2 = 0.64; P < 0.0001) within HS3ST3B1.
Linkage and association analyses
A regression-based procedure was applied for multipoint
linkage analysis using MERLIN. Based on the analysis of
the 20 SNPs, parasitaemia was genetically linked to the
region containing HS3ST3A1 and HS3ST3B1 after apply-
ing an FDR of 10% (Table 2), with a peak of linkage at
rs61729712 (LOD score = 1.207, P = 0.009). A linkage
was also detected based on the analysis of the 10 SNPs
with the highest Minor Allele Frequency (MAF) after
applying a FDR of 5% (Table 3); the peak of linkage
was, nevertheless, at rs115229628 (LOD score = 1.409, P
= 0.005).
Combined linkage and association between each SNP
and parasitaemia was further evaluated. FBAT showed
evidence of linkage and association between rs28470223
and parasitaemia (P = 0.005), whereas the other SNPs
were not associated with parasitaemia (P > 0.09). The
allele C was negatively associated with parasitaemia (Z =
-2.77; P = 0.005), whereas the allele T was positively
associated with parasitaemia (Z = 2.77; P = 0.005). This
result remained significant after applying an FDR of 5%,
and confirmed the linkage signal detected with MER-
LIN. Furthermore, the linkage was taken into account to
test the association between each SNP and parasitaemia
by using QTDT; an association in the presence of link-
age was detected for rs28470223 (P <0.003) after apply-
ing an FDR of 5%.
Interaction analysis
The epistatic effect of HS3ST3A1 and HS3ST3B1 SNPs
was investigated, based on the knowledge of the biologi-
cal activity of HS3ST3A1 and HS3ST3B1. Two-, three-,
four-, and five-locus models were evaluated. Additional
file 2 shows the best models identified on the basis of
the classification parameters with the training set (Odds
Ratio and P value) and the cross-validation analysis with
the testing set (prediction accuracy and sign test P
value) after applying a FDR of 5%. The analysis revealed
73 significant multi-locus models, which could be con-
sistently cross-validated (Additional file 2). In other
words, the analysis of the training set yielded 73 binary
models with high and low risk genotype combinations,
which were significantly associated with parasitaemia,
and which were validated based on the testing set. All
the significant multi-locus models included SNPs
located in both HS3ST3A1 and HS3ST3B1. The signifi-
cant models included 19 of the 20 SNPs. These include:
i) rs3744337, rs3744335, rs28470223, rs78863672,
rs2072243, rs2072242, and rs115229628 that are located
within the 5’UTR region of either HS3ST3A1 or
HS3ST3B1: ii) rs3785655 and rs7379332 that are within
the 3’UTR region of HS3ST3B1; iii) rs9906855,
rs62057033, rs61732181, rs61744056, rs62636622 and
rs55688668 that are synonymous mutations of either
HS3ST3A1 or HS3ST3B1; and iv) rs62636623,
rs62056073, rs61729712, and rs9906590 that are mis-
sense mutations within HS3ST3B1. Interestingly,
rs28470223 was in 37 of the 73 significant multi-locus
models, and 38 multi-locus models contained at least
one mis-sense mutation.
Discussion
This is apparently the first study to investigate the asso-
ciation between a phenotype related to malaria suscept-
ibility and genes involved in HS biosynthesis. Two genes
700 kb apart, which encode 3-O sulphotransferases
involved in the synthesis of HS (HS3ST3A1 and
HS3ST3B1), were considered as candidate genes.
First, P. falciparum parasitaemia was found to be
genetically linked to HS3ST3A1 and HS3ST3B1 poly-
morphisms based on a multipoint linkage analysis. This
result is consistent with linkage studies based on micro-
satellite markers in mice [26,27] and humans (P. Rihet,
unpublished data). This suggests that polymorphisms
within the chromosomal region may partly explain the
variance of parasitaemia, and may affect resistance
against malaria. In the same way, rs6503319, which is
located in the human chromosomal region genetically
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linked to parasitaemia (P.Rihet, unpublished data), has
been associated with severe malaria [39]. It should be
stressed, however, that the location of the peak of
linkage depends on the SNPs included in the analysis.
This indicates either that the linkage analysis does not
accurately locate the causal polymorphisms, or that
Table 1 Overview of the polymorphisms genotyped in the African population
SNP Id a SNP rs# GRCh37 location (bp) Localization within gene Alleles b MAF c Molecular change
rs1047933 13399333 HS3ST3A1 3’UTR T > A - -
rs67951062 13399487 HS3ST3A1 3’UTR - > TTT - -
rs11385090 13399495 HS3ST3A1 3’UTR A > - - -
rs67556828 13399497 HS3ST3A1 3’UTR - > T - -
rs56160453 13399536 HS3ST3A1 ex2 A > G - mis-sense H [His] ⇒ R [Arg]
rs56184152 13399569 HS3ST3A1 ex2 C > T - mis-sense P [Pro] ⇒ L [Leu]
1 rs62057033 13399616 HS3ST3A1 ex2 T > A 0.069 Synonymous
rs55688668 13399778 HS3ST3A1 ex2 G > A - Synonymous
rs56408399 13399795 HS3ST3A1 ex2 C > T - mis-sense R [Arg] ⇒ W [Trp]
rs61729712 13399884 HS3ST3A1 ex2 G > A - mis-sense S [Ser] ⇒ N [Asn]
2 rs61732181 13399928 HS3ST3A1 ex2 G > A 0.043 Synonymous
rs55888783 13400004 HS3ST3A1 ex2 A > G - mis-sense D [Asp] ⇒ G [Gly]
rs56307410 13400014 HS3ST3A1 ex2 G > A - missense V [Val] ⇒ M [Met]
3 rs61744056 13400057 HS3ST3A1 ex2 C > T 0.005 Synonymous
4 rs8080565 13400153 HS3ST3A1 intron C > T 0.106 -
rs60532842 13504194 HS3ST3A1 ex1 C > A - mis-sense A [Ala] ⇒ S [Ser]
rs28663356 13504408 HS3ST3A1 ex1 C > A - Synonymous
rs73298111 13504474 HS3ST3A1 5’UTR C > T - -
5 rs3744337 13504665 HS3ST3A1 5’UTR C > T 0.330 -
rs3744336 13504689 HS3ST3A1 5’UTR A > T - -
rs34011501 13504833 HS3ST3A1 5’UTR - > T - -
6 rs3744335 13504884 HS3ST3A1 5’UTR A > C 0.320 -
7 rs28470223 13505023 HS3ST3A1 5’UTR C > T 0.161 -
8 rs78863672 13505237 HS3ST3A1 5’UTR G > T 0.433 -
rs67848311 13505244 intergenic C > - - -
rs58718148 13505245 intergenic C > - - -
9 rs2072243 14204380 HS3ST3B1 5’UTR C > T 0.150 -
10 rs2072242 14204410 HS3ST3B1 5’UTR T > C 0.184 -
11 rs115229628 14204423 HS3ST3B1 5’UTR G > A 0.097 -
rs72241295 14204547-14205186 HS3ST3B1 5’UTR ® ex1 639 bp del - Large deletion
12 rs62636623 14205082 HS3ST3B1 ex1 G > C 0.020 mis-sense G [Gly] ⇒ R [Arg]
13 rs62636622 14205168 HS3ST3B1 ex1 G > A 0.021 Synonymous
14 rs62056073 14248376 HS3ST3B1 ex2 A > G 0.009 mis-sense I [Ile] ⇒ V [Val]
15 rs9906855 14248423 HS3ST3B1 ex2 C > T 0.173 synonymous
rs56307410 14248466 HS3ST3B1 ex2 G > A - mis-sense V [Val] ⇒ M [Met]
rs55888783 14248476 HS3ST3B1 ex2 A > G - mis-sense D [Asp] ⇒ G [Gly]
rs61732181 14248552 HS3ST3B1 ex2 G > T/C - synonymous
16 rs61729712 14248596 HS3ST3B1 ex2 G > A 0.006 mis-sense S [Ser] ⇒ N [Asn]
rs56408399 14248685 HS3ST3B1 ex2 C > T - mis-sense R [Arg] ⇒ W [Trp]
17 rs55688668 14248702 HS3ST3B1 ex2 G > A 0.066 synonymous
rs61741326 14248864 HS3ST3B1 ex2 T > A - synonymous
18 rs9906590 14248877 HS3ST3B1 ex2 G > A 0.098 mis-sense E [Glu] ⇒ K [Lys]
rs56184152 14248911 HS3ST3B1 ex2 C > T - mis-sense P [Pro] ⇒ L [Leu]
rs56160453 14248944 HS3ST3B1 ex2 A > G - missense H [His] ⇒ R [Arg]
19 rs3785655 14249167 HS3ST3B1 3’UTR C > T 0.059 -
20 rs7379332 14249433 HS3ST3B1 3’UTR C > T 0.070 -
aDetected SNPs are shown. bMajor allele > minor allele. cAllele frequency that was calculated in the study population is shown
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several polymorphisms within the region may influence
parasitaemia.
Second, linkage and association between parasitaemia
and rs28470223 was detected. Thus, this one-locus ana-
lysis confirmed the linkage signal obtained with the
multipoint analysis. Furthermore, rs28470223, which is
located within the promoter of HS3ST3A1, was asso-
ciated in the presence of linkage with parasitaemia. This
supports the hypothesis that rs28470223 alters both the
expression of HS3ST3A1 and parasitaemia. Functional
studies will be required to evaluate whether rs28470223
affects the binding of a transcription factor, and the
Figure 1 (A) Diagram of the HS3ST3A1/HS3ST3B1 locus. (B) Location of the known SNPs in relation to the intron/exon structure of HS3ST3A1
and HS3ST3B1. The SNPs that were detected are in bold. The 5’- and 3’-UTRs are shown by white boxes and the coding exons are shown by
hatched boxes. The regions that encode the sulphotransferase domain are shown.
Figure 2 Pair-wise linkage disequilibrium map within HS3ST3A1
and HS3ST3B1. Dark denotes highly significant linkage
disequilibrium. R2 multiplied by 100 value is shown.
Table 2 Multi-point linkage analyses of parasitaemia to
HS3ST3A1 and HS3ST3B1 based on the 20 SNPs
SNP Id SNP rs# LOD P value
1 rs62057033 0.578 0.05
2 rs61732181 0.578 0.05
3 rs61744056 0.610 0.05
4 rs8080565 0.578 0.05
5 rs3744337 0.682 0.04
6 rs3744335 0.634 0.04
7 rs28470223 0.636 0.04
8 rs78863672 0.631 0.04
9 rs2072243 1.111 0.012 a
10 rs2072242 1.106 0.012 a
11 rs115229628 1.144 0.011 a
12 rs62636623 1.138 0.011 a
13 rs62636622 1.140 0.011 a
14 rs62056073 1.136 0.011 a
15 rs9906855 1.157 0.010 a
16 rs61729712 1.207 0.009 a
17 rs55688668 1.199 0.009 a
18 rs9906590 1.199 0.009 a
19 rs3785655 1.200 0.009 a
20 rs7379332 1.201 0.009 a
aSignificant P value after applying an FDR of 10%
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level of gene expression. However, it cannot be excluded
that rs28470223 is in linkage disequilibrium with the
causal polymorphism.
Third, given that HS3ST3A1 and HS3ST3B1 encode
enzymes with a nearly identical activity, a gene-by-gene
interaction analysis was conducted based on the
PGMDR approach [28]. Two-, three-, four, and five-
locus interactions were systematically evaluated.
Seventy-three significant multi-locus models, which
included SNPs found in both HS3ST3A1 and
HS3ST3B1, were identified. This supports the hypothesis
of epistatic interaction between HS3ST3A1 and
HS3ST3B1. In addition, 37 out of the 73 significant
multi-locus models included rs28470223 located in the
promoter of HS3ST3A1, further supporting the hypoth-
esis of a particular role for rs28470223. Other SNPs
located in the promoter of either HS3ST3A1 or
HS3ST3B1 and synonymous mutations, which may alter
gene expression levels, were also included in several sig-
nificant multi-locus models. Moreover, 38 multi-locus
models contained at least one mis-sense mutation. This
suggests a possible functional role of rs62636623,
rs62056073, rs61729712, and rs9906590, which alter the
sequence of amino acids. rs62056073, rs61729712, and
rs9906590 are of major interest because they affect the
sulphotransferase domain, suggesting that they may alter
the enzymatic activity. Interestingly, site-directed muta-
genesis experiments have demonstrated that several
amino acid changes in the sulphotransferase domain
dramatically reduce the enzymatic activity [40]. In addi-
tion, rs62056073, rs61729712, and rs9906590 are close
to known mutations that result in the loss of the enzy-
matic activity [40].
In all, the results suggest that several SNPs within
HS3ST3A1 and HS3ST3B1, the genes encoding 3-OST-
3A1 and 3-OST-3B1, may cause variations in either
gene expression levels or the enzymatic activity, and
that this may result in variations in parasitaemia. Two
mechanisms may explain how genetic variations in
HS3ST3A1 and HS3ST3B1 may result in variations in
parasitaemia. Genetic variations in HS3ST3A1 and
HS3ST3B1 that alter the 3-O sulphation of HS may
affect i) the binding of P. falciparum antigen on host
cells and/or ii) the pro-inflammatory response.
Together with previous reports [2-4,41], the results
suggest that variations in the 3-O sulphation catalyzed
by 3-OST-3A1 and 3-OST-3B1 may affect both the
binding of P. falciparum antigen on host cells and the
parasite invasion rate. Highly sulphated HS has been
shown to promote a productive invasion of cells by P.
berghei sporozoites, whereas sporozoites migrate
through cells harbouring low sulphated HS [2]. Since
the 3-O sulphation is the last step of HS synthesis and
occurs after the 2-O and 6-0 sulphation steps, one
might assume that highly sulphated HS involved in the
sporozoite invasion is 3-O sulphated. This hypothesis is
consistent with the data showing that 2-O, 3-O, and N
sulphate moieties participate in sporozoite CSP binding
[41]. Although the N-sulphation has been shown to be
involved in rosette disruption [4-6], and although the O-
sulphation has not been reported to influence either the
binding of P. falciparum antigen on the human erythro-
cyte surface or the merozoite invasion rate [3], the
results showing the inhibition of merozoite invasion by
heparin and other highly sulphated glycoconjugates
[42,43], and those showing the influence of the O-sul-
phation on hepatocyte invasion by sporozoites makes
this hypothesis relevant.
Genetic variations in HS3ST3A1 and HS3ST3B1
might also alter the immune response, and more speci-
fically, the inflammatory response. Indeed, pro-inflam-
matory cytokine and chemokine binding to HS that
depends on the sulphation profile of HS controls both
the tissue targeting and the local accumulation of cyto-
kines and chemokines [44,45]. Interestingly, CCR5
(chemokine (C-C motif) receptor 5) up-regulation was
associated with the up-regulation of HS3ST3A1 and
HS3ST3B1 in humans infected by HIV; the authors
suggested either that interaction between HS and
CCR5 causes up-regulation, or that the promoters of
CCR5, HS3ST3A1 and HS3ST3B1 share a cis-regula-
tory motif binding the same transcription factor [46].
Since CCR5 and HS3ST3A1 have been associated with
HIV infection [12,47], this suggests an interaction at
the genetic level affecting resistance to HIV infection.
By extension, this suggests that the interaction between
immune genes and genes involved in HS biosynthesis
may contribute to resistance against other infectious
diseases, such as malaria. Additional investigations are
Table 3 Multi-point linkage analyses of parasitaemia to
HS3ST3A1 and HS3ST3B1 based on the 10 SNPs having
the highest MAF
SNP Id SNP rs# LOD P value
4 rs8080565 0.548 0.06
5 rs3744337 0.735 0.03
6 rs3744335 0.684 0.04
7 rs28470223 0.749 0.03
8 rs78863672 0.743 0.03
9 rs2072243 1.258 0.008 a
10 rs2072242 1.361 0.006 a, b
11 rs115229628 1.409 0.005 a, b
15 rs9906855 0.684 0.04
18 rs9906590 0.684 0.04
aSignificant P value after applying an FDR of 10%
bSignificant P value after applying an FDR of 5%
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needed to evaluate the role of such genetic interac-
tions, and to elucidate how the sulphation profile of
HS determines cytokine and chemokine binding.
Conclusions
This study shows that HS3ST3A1 and HS3ST3B1 are
linked to P. falciparum parasitaemia, that rs28470223
within the promoter of HS3ST3A1 is associated with P.
falciparum parasitaemia, and that interactions between
HS3ST3A1 and HS3ST3B1 polymorphisms alter P. falci-
parum parasitaemia. The results also indicate that
rs28470223 and four mis-sense mutations within
HS3ST3B1 strongly contribute to genetic interactions.
This study also suggests that other genes involved in HS
biosynthesis may affect malaria resistance. In this way,
NDST1 that plays a major role in HS biosynthesis is
located within the chromosome 5q31-q33, which is
linked to P. falciparum parasitaemia [15].
Additional material
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PGMDR. All the P values were significant after applying a FDR of 5%.
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